Organ preservation with chemoradiation in advanced laryngeal cancer

The problem of generalizing results from randomized controlled trials

Alvaro Sanabria, Aline L F Chaves, Luiz P. Kowalski, Gregory T. Wolf, Nabil F. Saba, Arlene A. Forastiere, Jonathan J. Beitler, Ken ichi Nibu, Carol R. Bradford, Carlos Suárez, Juan P. Rodrigo, Primož Strojan, Alessandra Rinaldo, Remco de Bree, Missak Haigentz, Robert P. Takes, Alfio Ferlito

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Background The primary goal of treatment in advanced laryngeal cancer is to achieve optimal oncologic outcomes while preserving function and quality of life. Combination of chemotherapy and radiation has been popularized as an alternative to surgery for patients facing total laryngectomy. However, survival analyses from large, population-based databases have not duplicated results reported from randomized trials. Methods A comprehensive literature review was undertaken to try to better understand the reasons why results differ among randomized trials and population cohort studies. Results A variety of reasons are discussed, including differences in patient staging, selection bias, complexity bias, inconsistent terminology, patient compliance and treatment expertise. Conclusions Personalized treatment considering all factors is critical for optimal outcomes. In general, evidence supports total laryngectomy for patients with T4 cancers. Definitive chemoradiotherapy strategies are acceptable alternatives for T3 cancers, provided that all resources for the administration of the treatment, follow-up and surgical salvage are available.

Original languageEnglish (US)
Pages (from-to)18-25
Number of pages8
JournalAuris Nasus Larynx
Volume44
Issue number1
DOIs
StatePublished - Feb 1 2017

Fingerprint

Organ Preservation
Laryngeal Neoplasms
Randomized Controlled Trials
Laryngectomy
Selection Bias
Chemoradiotherapy
Therapeutics
Survival Analysis
Patient Compliance
Combination Drug Therapy
Terminology
Patient Selection
Population
Neoplasms
Cohort Studies
Quality of Life
Databases
Radiation

Keywords

  • Advanced laryngeal cancer
  • Bias
  • Chemoradiotherapy
  • Controlled clinical trials
  • Laryngeal neoplasm
  • Laryngectomy
  • Organ preservation
  • Outcomes assessment

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Cite this

Sanabria, A., Chaves, A. L. F., Kowalski, L. P., Wolf, G. T., Saba, N. F., Forastiere, A. A., ... Ferlito, A. (2017). Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trials. Auris Nasus Larynx, 44(1), 18-25. https://doi.org/10.1016/j.anl.2016.06.005

Organ preservation with chemoradiation in advanced laryngeal cancer : The problem of generalizing results from randomized controlled trials. / Sanabria, Alvaro; Chaves, Aline L F; Kowalski, Luiz P.; Wolf, Gregory T.; Saba, Nabil F.; Forastiere, Arlene A.; Beitler, Jonathan J.; Nibu, Ken ichi; Bradford, Carol R.; Suárez, Carlos; Rodrigo, Juan P.; Strojan, Primož; Rinaldo, Alessandra; de Bree, Remco; Haigentz, Missak; Takes, Robert P.; Ferlito, Alfio.

In: Auris Nasus Larynx, Vol. 44, No. 1, 01.02.2017, p. 18-25.

Research output: Contribution to journalReview article

Sanabria, A, Chaves, ALF, Kowalski, LP, Wolf, GT, Saba, NF, Forastiere, AA, Beitler, JJ, Nibu, KI, Bradford, CR, Suárez, C, Rodrigo, JP, Strojan, P, Rinaldo, A, de Bree, R, Haigentz, M, Takes, RP & Ferlito, A 2017, 'Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trials', Auris Nasus Larynx, vol. 44, no. 1, pp. 18-25. https://doi.org/10.1016/j.anl.2016.06.005
Sanabria, Alvaro ; Chaves, Aline L F ; Kowalski, Luiz P. ; Wolf, Gregory T. ; Saba, Nabil F. ; Forastiere, Arlene A. ; Beitler, Jonathan J. ; Nibu, Ken ichi ; Bradford, Carol R. ; Suárez, Carlos ; Rodrigo, Juan P. ; Strojan, Primož ; Rinaldo, Alessandra ; de Bree, Remco ; Haigentz, Missak ; Takes, Robert P. ; Ferlito, Alfio. / Organ preservation with chemoradiation in advanced laryngeal cancer : The problem of generalizing results from randomized controlled trials. In: Auris Nasus Larynx. 2017 ; Vol. 44, No. 1. pp. 18-25.
@article{18c9a92f063d42179d3b4bdea9432bd6,
title = "Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trials",
abstract = "Background The primary goal of treatment in advanced laryngeal cancer is to achieve optimal oncologic outcomes while preserving function and quality of life. Combination of chemotherapy and radiation has been popularized as an alternative to surgery for patients facing total laryngectomy. However, survival analyses from large, population-based databases have not duplicated results reported from randomized trials. Methods A comprehensive literature review was undertaken to try to better understand the reasons why results differ among randomized trials and population cohort studies. Results A variety of reasons are discussed, including differences in patient staging, selection bias, complexity bias, inconsistent terminology, patient compliance and treatment expertise. Conclusions Personalized treatment considering all factors is critical for optimal outcomes. In general, evidence supports total laryngectomy for patients with T4 cancers. Definitive chemoradiotherapy strategies are acceptable alternatives for T3 cancers, provided that all resources for the administration of the treatment, follow-up and surgical salvage are available.",
keywords = "Advanced laryngeal cancer, Bias, Chemoradiotherapy, Controlled clinical trials, Laryngeal neoplasm, Laryngectomy, Organ preservation, Outcomes assessment",
author = "Alvaro Sanabria and Chaves, {Aline L F} and Kowalski, {Luiz P.} and Wolf, {Gregory T.} and Saba, {Nabil F.} and Forastiere, {Arlene A.} and Beitler, {Jonathan J.} and Nibu, {Ken ichi} and Bradford, {Carol R.} and Carlos Su{\'a}rez and Rodrigo, {Juan P.} and Primož Strojan and Alessandra Rinaldo and {de Bree}, Remco and Missak Haigentz and Takes, {Robert P.} and Alfio Ferlito",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.anl.2016.06.005",
language = "English (US)",
volume = "44",
pages = "18--25",
journal = "Auris Nasus Larynx",
issn = "0385-8146",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Organ preservation with chemoradiation in advanced laryngeal cancer

T2 - The problem of generalizing results from randomized controlled trials

AU - Sanabria, Alvaro

AU - Chaves, Aline L F

AU - Kowalski, Luiz P.

AU - Wolf, Gregory T.

AU - Saba, Nabil F.

AU - Forastiere, Arlene A.

AU - Beitler, Jonathan J.

AU - Nibu, Ken ichi

AU - Bradford, Carol R.

AU - Suárez, Carlos

AU - Rodrigo, Juan P.

AU - Strojan, Primož

AU - Rinaldo, Alessandra

AU - de Bree, Remco

AU - Haigentz, Missak

AU - Takes, Robert P.

AU - Ferlito, Alfio

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Background The primary goal of treatment in advanced laryngeal cancer is to achieve optimal oncologic outcomes while preserving function and quality of life. Combination of chemotherapy and radiation has been popularized as an alternative to surgery for patients facing total laryngectomy. However, survival analyses from large, population-based databases have not duplicated results reported from randomized trials. Methods A comprehensive literature review was undertaken to try to better understand the reasons why results differ among randomized trials and population cohort studies. Results A variety of reasons are discussed, including differences in patient staging, selection bias, complexity bias, inconsistent terminology, patient compliance and treatment expertise. Conclusions Personalized treatment considering all factors is critical for optimal outcomes. In general, evidence supports total laryngectomy for patients with T4 cancers. Definitive chemoradiotherapy strategies are acceptable alternatives for T3 cancers, provided that all resources for the administration of the treatment, follow-up and surgical salvage are available.

AB - Background The primary goal of treatment in advanced laryngeal cancer is to achieve optimal oncologic outcomes while preserving function and quality of life. Combination of chemotherapy and radiation has been popularized as an alternative to surgery for patients facing total laryngectomy. However, survival analyses from large, population-based databases have not duplicated results reported from randomized trials. Methods A comprehensive literature review was undertaken to try to better understand the reasons why results differ among randomized trials and population cohort studies. Results A variety of reasons are discussed, including differences in patient staging, selection bias, complexity bias, inconsistent terminology, patient compliance and treatment expertise. Conclusions Personalized treatment considering all factors is critical for optimal outcomes. In general, evidence supports total laryngectomy for patients with T4 cancers. Definitive chemoradiotherapy strategies are acceptable alternatives for T3 cancers, provided that all resources for the administration of the treatment, follow-up and surgical salvage are available.

KW - Advanced laryngeal cancer

KW - Bias

KW - Chemoradiotherapy

KW - Controlled clinical trials

KW - Laryngeal neoplasm

KW - Laryngectomy

KW - Organ preservation

KW - Outcomes assessment

UR - http://www.scopus.com/inward/record.url?scp=85003707645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85003707645&partnerID=8YFLogxK

U2 - 10.1016/j.anl.2016.06.005

DO - 10.1016/j.anl.2016.06.005

M3 - Review article

VL - 44

SP - 18

EP - 25

JO - Auris Nasus Larynx

JF - Auris Nasus Larynx

SN - 0385-8146

IS - 1

ER -